Recombinant bovine immunodeficiency virus-like particles comprising an influenza HA transmembrane domain and C-terminus
US12303560B2 · kind B2 · utility
0Cited by
2References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 12, 2023 |
| Grant date | May 20, 2025 |
| Priority date | — |
| Expiry date | Jan 12, 2043 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are Bovine immunodeficiency virus gag protein (“Bgag”) recombinant virus like particles (“VLPs”) comprising one or more different types of target pathogen proteins. Also described, are compositions comprising the novel Bgag VLPs and the methods of making and using the novel Bgag VLPs.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.